E2F3 and breast carcinoma: Zang et al. discovered that CircRNF111 is overexpressed in paclitaxel-resistant breast cancer cells and functions as a miRNA sponge to negatively regulate miR-140-5p and upregulate E2F transcription factor 3 (E2F3), resulting in paclitaxel-resistant breast cancer cells.